• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘磷脂合酶作为D609诱导U937人单核细胞白血病细胞凋亡的潜在靶点。

Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells.

作者信息

Meng Aimin, Luberto Chiara, Meier Patrick, Bai Aiping, Yang Xiaofeng, Hannun Yusuf A, Zhou Daohong

机构信息

Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.

出版信息

Exp Cell Res. 2004 Jan 15;292(2):385-92. doi: 10.1016/j.yexcr.2003.10.001.

DOI:10.1016/j.yexcr.2003.10.001
PMID:14697345
Abstract

Tricyclodecan-9-yl-xanthogenate (D609) is a selective tumor cytotoxic agent. However, the mechanisms of action of D609 against tumor cells have not been well established. Using U937 human monocytic leukemia cells, we examined the ability of D609 to inhibit sphingomyelin synthase (SMS), since inhibition of SMS may contribute to D609-induced tumor cell cytotoxicity via modulating the cellular levels of ceramide and diacylglycerol (DAG). The results showed that D609 is capable of inducing U937 cell death by apoptosis in a dose- and time-dependent manner. The induction of U937 cell apoptosis was associated with an inhibition of SMS activity and a significant increase in the intracellular level of ceramide and decrease in that of sphingomyelin (SM) and DAG, which resulted in an elevation of the ratio between ceramide and DAG favoring the induction of apoptosis. In addition, incubation of U937 cells with C(6)-ceramide and/or H7 (a selective PKC inhibitor) reduced U937 cell viability; whereas pretreatment of the cells with a PKC activator, PMA or 1-oleoyl-2-acetylglycerol (OAG), attenuated D609-induced U937 cell apoptosis. These results suggest that SMS is a potential target of D609 and inhibition of SMS may contribute to D609-induced tumor cell death via modulation of the cellular levels of ceramide and DAG.

摘要

三环癸烷-9-基-黄原酸酯(D609)是一种选择性肿瘤细胞毒性剂。然而,D609对肿瘤细胞的作用机制尚未完全明确。我们使用U937人单核细胞白血病细胞,研究了D609抑制鞘磷脂合酶(SMS)的能力,因为抑制SMS可能通过调节神经酰胺和二酰基甘油(DAG)的细胞水平,导致D609诱导的肿瘤细胞毒性。结果表明,D609能够以剂量和时间依赖性方式诱导U937细胞凋亡。U937细胞凋亡的诱导与SMS活性的抑制以及神经酰胺细胞内水平的显著增加、鞘磷脂(SM)和DAG水平的降低有关,这导致神经酰胺与DAG的比例升高,有利于凋亡的诱导。此外,用C(6)-神经酰胺和/或H7(一种选择性PKC抑制剂)孵育U937细胞会降低U937细胞活力;而用PKC激活剂PMA或1-油酰-2-乙酰甘油(OAG)预处理细胞,则会减弱D609诱导的U937细胞凋亡。这些结果表明,SMS是D609的潜在靶点,抑制SMS可能通过调节神经酰胺和DAG的细胞水平,导致D609诱导的肿瘤细胞死亡。

相似文献

1
Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells.鞘磷脂合酶作为D609诱导U937人单核细胞白血病细胞凋亡的潜在靶点。
Exp Cell Res. 2004 Jan 15;292(2):385-92. doi: 10.1016/j.yexcr.2003.10.001.
2
Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C?鞘磷脂合酶,一种在SV40转化过程中细胞内神经酰胺和二酰甘油水平的潜在调节因子。鞘磷脂合酶是否就是所谓的磷脂酰胆碱特异性磷脂酶C?
J Biol Chem. 1998 Jun 5;273(23):14550-9. doi: 10.1074/jbc.273.23.14550.
3
Induction of apoptosis and potentiation of TNF- and Fas-mediated apoptosis in U937 cells by the xanthogenate compound D609.黄原酸酯化合物D609诱导U937细胞凋亡以及增强TNF和Fas介导的细胞凋亡
Exp Cell Res. 1997 Aug 25;235(1):48-54. doi: 10.1006/excr.1997.3641.
4
Anti-proliferative effects of tricyclodecan-9-yl-xanthogenate (D609) involve ceramide and cell cycle inhibition.三癸基-[9]-硫代黄原酸酯(D609)的抗增殖作用涉及神经酰胺和细胞周期抑制。
Mol Neurobiol. 2012 Jun;45(3):455-64. doi: 10.1007/s12035-012-8254-0. Epub 2012 Mar 14.
5
Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.抑制鞘磷脂合酶(SMS)会影响细胞内鞘磷脂的积累以及质膜脂质组织。
Biochim Biophys Acta. 2007 Sep;1771(9):1186-94. doi: 10.1016/j.bbalip.2007.05.007. Epub 2007 Jun 6.
6
Prodrug modification increases potassium tricyclo[5.2.1.0(2,6)]-decan-8-yl dithiocarbonate (D609) chemical stability and cytotoxicity against U937 leukemia cells.
J Pharmacol Exp Ther. 2004 Jun;309(3):1051-9. doi: 10.1124/jpet.103.064600. Epub 2004 Feb 11.
7
The tricyclodecan-9-yl-xanthogenate D609 triggers ceramide increase and enhances FasL-induced caspase-dependent and -independent cell death in T lymphocytes.三环癸烷-9-基-黄原酸酯D609可引发神经酰胺增加,并增强FasL诱导的T淋巴细胞中半胱天冬酶依赖性和非依赖性细胞死亡。
Int J Mol Sci. 2012;13(7):8834-8852. doi: 10.3390/ijms13078834. Epub 2012 Jul 16.
8
Effect of tricyclodecan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen-glucose deprivation in PC12 cells.三环癸烷-9-基黄原酸钾(D609)对PC12细胞氧糖剥夺期间磷脂代谢和细胞死亡的影响。
Neuroscience. 2007 May 25;146(3):946-61. doi: 10.1016/j.neuroscience.2007.02.022. Epub 2007 Apr 16.
9
Role of diacylglycerol induced by hypoxia in the regulation of HIF-1alpha activity.
Biochem Biophys Res Commun. 2004 Feb 27;315(1):44-50. doi: 10.1016/j.bbrc.2004.01.015.
10
The role of de novo ceramide synthesis in the mechanism of action of the tricyclic xanthate D609.从头合成神经酰胺在三环黄原酸盐D609作用机制中的作用。
J Lipid Res. 2004 Jan;45(1):164-73. doi: 10.1194/jlr.M300300-JLR200. Epub 2003 Sep 16.

引用本文的文献

1
A Review Discussing Synthesis and Translational Studies of Medicinal Agents Targeting Sphingolipid Pathways.一篇关于靶向鞘脂途径的药物合成与转化研究的综述
Biomolecules. 2025 Jul 16;15(7):1022. doi: 10.3390/biom15071022.
2
Ceramide Is Involved in Temozolomide Resistance in Human Glioblastoma U87MG Overexpressing EGFR.神经酰胺参与 EGFR 过表达的人胶质母细胞瘤 U87MG 对替莫唑胺的耐药。
Int J Mol Sci. 2023 Oct 20;24(20):15394. doi: 10.3390/ijms242015394.
3
Drug Development in the Field of Sphinogolipid Metabolism.鞘脂代谢领域的药物研发。
Adv Exp Med Biol. 2022;1372:169-188. doi: 10.1007/978-981-19-0394-6_12.
4
Tricyclodecan-9-yl-Xanthogenate (D609): Mechanism of Action and Pharmacological Applications.三环癸烷-9-基黄原酸酯(D609):作用机制和药理应用。
Int J Mol Sci. 2022 Mar 18;23(6):3305. doi: 10.3390/ijms23063305.
5
Ceramide and Related Molecules in Viral Infections.神经酰胺及相关分子在病毒感染中的作用
Int J Mol Sci. 2021 May 26;22(11):5676. doi: 10.3390/ijms22115676.
6
Ceramide/Sphingomyelin Rheostat Regulated by Sphingomyelin Synthases and Chronic Diseases in Murine Models.鞘磷脂合酶调控的神经酰胺/鞘磷脂变阻器与小鼠模型中的慢性疾病
J Lipid Atheroscler. 2020 Sep;9(3):380-405. doi: 10.12997/jla.2020.9.3.380. Epub 2020 Jul 29.
7
Antineoplastic Agents Targeting Sphingolipid Pathways.靶向鞘脂途径的抗肿瘤药物。
Front Oncol. 2020 May 22;10:833. doi: 10.3389/fonc.2020.00833. eCollection 2020.
8
Approaches for probing and evaluating mammalian sphingolipid metabolism.探测和评估哺乳动物神经酰胺代谢的方法。
Anal Biochem. 2019 Jun 15;575:70-86. doi: 10.1016/j.ab.2019.03.014. Epub 2019 Mar 24.
9
Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.新型基于神经酰胺的癌症治疗药物在个性化医疗时代的应用
Adv Cancer Res. 2018;140:327-366. doi: 10.1016/bs.acr.2018.04.016. Epub 2018 Jun 19.
10
Dihydroartemisinin-regulated mRNAs and lncRNAs in chronic myeloid leukemia.双氢青蒿素对慢性粒细胞白血病中mRNA和lncRNA的调控
Oncotarget. 2017 Dec 15;9(2):2543-2552. doi: 10.18632/oncotarget.23274. eCollection 2018 Jan 5.